Nanalysis Scientific Corp.
NSCIF
$0.11
$0.0112.66%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.53% | -5.67% | 5.90% | 24.66% | 57.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.53% | -5.67% | 5.90% | 24.66% | 57.44% |
| Cost of Revenue | -9.76% | -9.46% | -2.31% | 7.96% | 31.83% |
| Gross Profit | -23.25% | 6.39% | 34.39% | 99.62% | 215.40% |
| SG&A Expenses | -12.28% | -7.93% | -5.32% | -6.10% | -10.39% |
| Depreciation & Amortization | -28.19% | -14.32% | -7.73% | -6.87% | -1.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.13% | -9.31% | -3.49% | 2.49% | 14.98% |
| Operating Income | -6.12% | 36.51% | 53.16% | 73.33% | 74.56% |
| Income Before Tax | 59.04% | -64.88% | -0.39% | 17.23% | 20.85% |
| Income Tax Expenses | 179.49% | -99.37% | -100.76% | -96.20% | -6.12% |
| Earnings from Continuing Operations | 58.85% | -45.33% | 6.30% | 20.10% | 20.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.85% | -45.33% | 6.30% | 18.89% | 18.02% |
| EBIT | -6.12% | 36.51% | 53.16% | 73.33% | 74.56% |
| EBITDA | -1,275.11% | -43.27% | 53.95% | 99.56% | 102.65% |
| EPS Basic | 60.02% | -36.78% | 14.36% | 27.40% | 26.73% |
| Normalized Basic EPS | 20.86% | 32.94% | 45.71% | 58.57% | 56.29% |
| EPS Diluted | 58.52% | -25.96% | 10.60% | 22.92% | 22.73% |
| Normalized Diluted EPS | 20.86% | 32.94% | 45.71% | 58.57% | 56.29% |
| Average Basic Shares Outstanding | 3.68% | 5.53% | 8.06% | 11.62% | 11.57% |
| Average Diluted Shares Outstanding | 3.68% | 5.53% | 8.06% | 11.62% | 11.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |